DK154283A - Produkter og metoder til behandling af cancer - Google Patents

Produkter og metoder til behandling af cancer Download PDF

Info

Publication number
DK154283A
DK154283A DK154283A DK154283A DK154283A DK 154283 A DK154283 A DK 154283A DK 154283 A DK154283 A DK 154283A DK 154283 A DK154283 A DK 154283A DK 154283 A DK154283 A DK 154283A
Authority
DK
Denmark
Prior art keywords
methods
cancer treatment
treatment products
products
cancer
Prior art date
Application number
DK154283A
Other languages
Danish (da)
English (en)
Other versions
DK154283D0 (da
Inventor
David Stephen Terman
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of DK154283D0 publication Critical patent/DK154283D0/da
Publication of DK154283A publication Critical patent/DK154283A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK154283A 1982-04-07 1983-04-07 Produkter og metoder til behandling af cancer DK154283A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36643682A 1982-04-07 1982-04-07
US47236283A 1983-03-11 1983-03-11

Publications (2)

Publication Number Publication Date
DK154283D0 DK154283D0 (da) 1983-04-07
DK154283A true DK154283A (da) 1983-10-08

Family

ID=27003359

Family Applications (1)

Application Number Title Priority Date Filing Date
DK154283A DK154283A (da) 1982-04-07 1983-04-07 Produkter og metoder til behandling af cancer

Country Status (13)

Country Link
EP (1) EP0091784B1 (fr)
AU (2) AU569467B2 (fr)
CA (1) CA1230555A (fr)
DE (1) DE3374756D1 (fr)
DK (1) DK154283A (fr)
ES (5) ES8405621A1 (fr)
FI (1) FI831169A7 (fr)
GB (2) GB2119803B (fr)
GR (1) GR78514B (fr)
NO (5) NO831223L (fr)
PT (1) PT76505B (fr)
RO (3) RO86661A (fr)
ZW (1) ZW7583A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161813B (en) * 1984-07-20 1988-07-13 Michiko Koga Anti-tumor agent
GB9013872D0 (en) * 1990-06-21 1990-08-15 Inst Tecnologico Y Cientifico Use of protein a and polypeptide components thereof in the treatment of tumours
EP0694066A4 (fr) * 1993-04-08 1997-01-29 Univ Texas Modeles pour infection gonococcique
GB2422311A (en) * 2005-01-20 2006-07-26 Martin Lister Treatment of blood to cure disease
DE102005012594A1 (de) 2005-03-18 2006-09-21 Bayer Technology Services Gmbh Elektrofiltrationsverfahren
SG176064A1 (en) * 2009-05-14 2011-12-29 Oatmeal Biotechnologies Group L L C Platform technologies for spontaneously occurring diseases
EP3426265B1 (fr) * 2016-04-28 2021-09-22 Alkahest, Inc. Utilisation de fractions de plasma sanguin contre la croissance et la progression tumorale
IL304946A (en) 2016-08-18 2023-10-01 Alkahest Inc Blood plasma fractions as a treatment for cognitive disorders associated with aging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
FI791551A7 (fi) * 1978-05-17 1981-01-01 As Alfred Benzon Puhdistettu syöpäassosioitunut proteiini.

Also Published As

Publication number Publication date
NO831223L (no) 1983-10-10
AU1560088A (en) 1988-10-27
RO89496A (fr) 1986-06-30
AU1286583A (en) 1983-10-13
NO841495L (no) 1983-10-10
RO89498A (fr) 1986-06-30
AU569467B2 (en) 1988-02-04
EP0091784A2 (fr) 1983-10-19
GB8510892D0 (en) 1985-06-05
ES528118A0 (es) 1985-04-16
NO841496L (no) 1983-10-10
ES8503954A1 (es) 1985-04-16
ES8503950A1 (es) 1985-04-16
ES528121A0 (es) 1985-11-01
RO86661B (ro) 1985-03-01
FI831169L (fi) 1983-10-08
PT76505A (en) 1983-05-01
ES8601703A1 (es) 1985-11-01
GB2119803B (en) 1986-09-03
GR78514B (fr) 1984-09-27
NO841497L (no) 1983-10-10
GB2163164A (en) 1986-02-19
FI831169A7 (fi) 1983-10-08
ES8503953A1 (es) 1985-04-16
PT76505B (en) 1986-05-05
GB2119803A (en) 1983-11-23
DK154283D0 (da) 1983-04-07
FI831169A0 (fi) 1983-04-06
ES528119A0 (es) 1985-04-16
EP0091784A3 (en) 1984-07-11
ES521279A0 (es) 1984-06-16
ZW7583A1 (en) 1983-06-29
CA1230555A (fr) 1987-12-22
ES528120A0 (es) 1985-04-16
DE3374756D1 (en) 1988-01-14
ES8405621A1 (es) 1984-06-16
NO841498L (no) 1983-10-10
RO86661A (fr) 1986-07-30
GB2163164B (en) 1986-09-03
GB8309348D0 (en) 1983-05-11
EP0091784B1 (fr) 1987-12-02

Similar Documents

Publication Publication Date Title
DK516883D0 (da) Fremgangsmade og anlaeg til diffraktionstomografi
DK343882A (da) Ostomiudstyr og fastgoerelsesplade hertil
DK159984C (da) Proces- eller behandlingsapparat
DK401583D0 (da) Parenkymal celle-cellulose og beslaegtede materialer
DK276683D0 (da) Carbapenemer og fremgangsmade til fremstilling deraf
DK462583D0 (da) Insekticidt produkt og fremgangsmade til fremstilling deraf
DK150361C (da) Afgroedebehandlingsapparat
DK144483D0 (da) Barbermaskine og barberingsenhed for barbermaskiner
DK590383A (da) Pyrimidonderivater og fremgangsmaade til fremstilling heraf
DK483083A (da) Platin-diamin komplekser og fremgangsmaade til fremstilling deraf
DK567781A (da) Phenoxyalkoxysilaner og fremgangsmaade til fremstilling heraf
NO822219L (no) Fremgangsmaate og anordning for komprimering av elementer av tre
DK537481A (da) 5-amino-1-phenyl-4-cyanpyrazoler og fremgangsmaade til fremstilling heraf
DK364583D0 (da) Apparat til harskaering og harpleje
DK154283D0 (da) Produkter og metoder til behandling af cancer
DK137582A (da) Praeparater i pulverform indeholdende pesticider og egnede til bahandling af bohave
DK352683A (da) Plastforet roersamling og fremgangsmaade til samling
DK404783D0 (da) Octahydrobenz (f) isoquinoliner og fremgangsmade til fremstilling heraf
DK297583A (da) Tricycliske forbindelser og fremgangsmaade til fremstilling heraf
DK481481A (da) Opsamlings og indkasseringsapparat til moenter
DK271281A (da) Haardfeldt og fremgangsmaade til fremstilling deraf
DK343183A (da) Ketoquinoliner og fremgangsmaade til fremstilling deraf
DK81192A (da) Substituerede ethandiimidamider og fremgangsmaade til fremstilling deraf
NO870125D0 (no) Fremgangsmaate og anordning for roerutlegning.
DK565783A (da) Terapeutisk praeparat indeholdende hydrogenerede ergotalkaloider og heparin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
PUP Patent expired